Biocon reports 95% YoY decline in net profit, operating revenue up 15%
Biocon posted a 95% year-on-year decline in reported net profit in the first quarter ended-June. However, the company claims to have on a like-for-like basis booked a 65% increase in profit after tax, after adjusting for the one-time divestment gains it made in the same quarter a year ago from the sale of metabolic, oncology…
